Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,925-9,936 of 10,661

Device study icon

Active Not RecruitingNCT05916417

TMS-fNIRS Personalized Dosing

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDeviceFrom 18 Years to 70 Years

Countries: United States
Sponsor: Florida State University
Condition: PTSD

Drug study icon

CompletedNCT03543137

To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers

This study is completed in the United States. It focuses on Addiction.

In United States

AddictionDrugFrom 19 Years to 55 Years

Countries: United States
Sponsor: GlaxoSmithKline
Condition: Addiction

Drug study icon

CompletedNCT00007774

To Determine if Olanzapine is More Cost Effective Than Haloperidol for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrug

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: Schizophrenia

Drug study icon

CompletedNCT06429722

Effects of NMRA-335140 on Symptoms of Major Depression in people with Bipolarity type II.

This study is completed in the United States. It focuses on depression.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Neumora Therapeutics, Inc.
Condition: Bipolarity, Depression

Behavioral study icon

TerminatedNCT02824445

Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: 72nd Medical Group, Tinker Air Force Base
Condition: PTSD

Drug study icon

CompletedNCT00141479

Impact of Treatment Interruption on Re-initiation of Bifeprunox

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Solvay Pharmaceuticals
Condition: Schizophrenia

Other study type icon

CompletedNCT01702142

To Test a Payer/Treatment Agency Intervention to Increase Use of Buprenorphine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalOver 17 Years

Countries: United States
Sponsor: University of Wisconsin, Madison
Condition: Addiction

Behavioral study icon

CompletedNCT00109460

Tobacco Cessation Field Study for Adults in Recovery - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Inflexxion, Inc.
Condition: Addiction

Behavioral study icon

CompletedNCT00908882

Tobacco Cessation for Veterans With PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: PTSD

Behavioral study icon

CompletedNCT00061061

Tobacco Cessation in Postmenopausal Women (Part I) - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 40 Years to 79 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Addiction

Drug study icon

CompletedNCT00061074

Tobacco Cessation in Postmenopausal Women (Part II) - 2

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 40 Years to 79 Years

Countries: United States
Sponsor: University of Minnesota
Condition: Addiction

Other study type icon

CompletedNCT01846065

Tobacco Craving and Triggers in Persons With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaObservationalFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.